Compare INTT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTT | CDXS |
|---|---|---|
| Founded | 1981 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.8M | 141.8M |
| IPO Year | 1997 | 2008 |
| Metric | INTT | CDXS |
|---|---|---|
| Price | $10.26 | $1.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | 46.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.54 |
| EPS | ★ N/A | N/A |
| Revenue | $66,801,000.00 | ★ $138,590,000.00 |
| Revenue This Year | N/A | $15.64 |
| Revenue Next Year | $11.31 | $5.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 66.06 | 32.30 |
| 52 Week Low | $5.24 | $1.05 |
| 52 Week High | $10.88 | $3.87 |
| Indicator | INTT | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 40.35 |
| Support Level | $7.04 | $1.12 |
| Resistance Level | $10.88 | $2.56 |
| Average True Range (ATR) | 0.58 | 0.09 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 68.80 | 41.94 |
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.